Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Accumulated Expenses (2024 - 2025)

Historic Accumulated Expenses for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q2 2025 value amounting to $523977.9.

  • Zhengye Biotechnology Holding's Accumulated Expenses changed N/A to $523977.9 in Q2 2025 from the same period last year, while for Jun 2025 it was $523977.9, marking a year-over-year change of. This contributed to the annual value of $781720.3 for FY2024, which is N/A changed from last year.
  • Zhengye Biotechnology Holding's Accumulated Expenses amounted to $523977.9 in Q2 2025.
  • Zhengye Biotechnology Holding's Accumulated Expenses' 5-year high stood at $781974.6 during Q4 2024, with a 5-year trough of $523977.9 in Q2 2025.